Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Andrii Dudnyk"'
Autor:
Andrii Dudnyk, Matthias Hempel, Oksana Lytvyniuk, Halyna Liudkevych, Volodymyr Matsera, Tetiana Nikitchenko, Svitlana Blyzniuk, Barbara Molina-Moya, Rosemarie Preyer, José Domínguez
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 18 (2024)
Background: Ukraine remains a high World Health Organization priority country for drug-resistant tuberculosis (TB). Rifampicin-resistant TB (RR-TB) has a more protracted, more complicated, and more expensive treatment. In 2021, Ukraine reported 4025
Externí odkaz:
https://doaj.org/article/e77352405d79418285050c398e578dec
Autor:
Matthias Merker, Elena Nikolaevskaya, Thomas A. Kohl, Barbara Molina-Moya, Olha Pavlovska, Patrik Brännberg, Andrii Dudnyk, Valentyna Stokich, Ivan Barilar, Iryna Marynova, Tetiana Filipova, Cristina Prat, Anders Sjöstedt, Jose Dominguez, Olena Rzhepishevska, Stefan Niemann
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 3, Pp 481-490 (2020)
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is an emerging threat to TB control in Ukraine, a country with the third highest XDR TB burden globally. We used whole-genome sequencing of a convenience sample to ident
Externí odkaz:
https://doaj.org/article/a0e064df5ca7447fae25e52ac148f9e0
Autor:
José Domínguez, Martin J Boeree, Emmanuelle Cambau, Dumitru Chesov, Francesca Conradie, Vivian Cox, Keertan Dheda, Andrii Dudnyk, Maha R Farhat, Sebastien Gagneux, Martin P Grobusch, Matthias I Gröschel, Lorenzo Guglielmetti, Irina Kontsevaya, Berit Lange, Frank van Leth, Christian Lienhardt, Anna M Mandalakas, Florian P Maurer, Matthias Merker, Paolo Miotto, Barbara Molina-Moya, Florence Morel, Stefan Niemann, Nicolas Veziris, Andrew Whitelaw, Charles R Horsburgh, Christoph Lange, Jose Domínguez, Martin J. Boeree, Maha R. Farhat, Martin P. Grobusch, Matthias I. Gröschel, Anna Maria Mandalakas, Florian Maurer, Charles Robert Horsburgh
Publikováno v:
Lancet Infectious Diseases, 23, e122-e137
TBnet and RESIST-TB networks 2023, ' Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis : a 2023 TBnet/RESIST-TB consensus statement ', The Lancet Infectious Diseases, vol. 23, no. 4, pp. e122-e137 . https://doi.org/10.1016/S1473-3099(22)00875-1
Lancet Infectious Diseases, 23, 4, pp. e122-e137
TBnet and RESIST-TB networks 2023, ' Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis : a 2023 TBnet/RESIST-TB consensus statement ', The Lancet Infectious Diseases, vol. 23, no. 4, pp. e122-e137 . https://doi.org/10.1016/S1473-3099(22)00875-1
Lancet Infectious Diseases, 23, 4, pp. e122-e137
Contains fulltext : 291526.pdf (Publisher’s version ) (Closed access) Drug-resistant tuberculosis is a substantial health-care concern worldwide. Despite culture-based methods being considered the gold standard for drug susceptibility testing, mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30842780d37cddcb7c56ba800fca9b87
https://doi.org/10.1016/S1473-3099(22)00875-1
https://doi.org/10.1016/S1473-3099(22)00875-1
Publikováno v:
European Respiratory Journal
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Acquired drug resistance (ADR) to antituberculosis medicines is commonly neglected issue in high tuberculosis (TB) burden countries. We aimed to determine the prevalence of ADR and factors associated with its occurrence during TB treatment in Ukraine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d21ca9ece07a1452d7f413a08c41f82d
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3273
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3273
Autor:
Patrik Brännberg, Iryna Marynova, Olena Rzhepishevska, José Domínguez, Elena Nikolaevskaya, Thomas Kohl, Stefan Niemann, Cristina Prat, Olha Pavlovska, Anders Sjöstedt, Tetiana Filipova, Andrii Dudnyk, Valentyna Stokich, Barbara Molina-Moya, Matthias Merker, Ivan Barilar
Publikováno v:
Emerging Infectious Diseases
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Emerging Infectious Diseases, Vol 26, Iss 3, Pp 481-490 (2020)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Emerging Infectious Diseases, Vol 26, Iss 3, Pp 481-490 (2020)
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is an emerging threat to TB control in Ukraine, a country with the third highest XDR TB burden globally. We used whole-genome sequencing of a convenience sample to ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d462aced4737480bc0de5fcec1a5ae2
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3525
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3525
Autor:
Andrii Dudnyk, Svitlana Blyzniuk, Dmytro Butov, Oleksandr Pavel’chuk, Olena Zakharchenko, Sergiі Zaіkov
Publikováno v:
Indian Journal of Tuberculosis. 65:63-69
Tuberculosis (TB) may have a similar spirometry findings as a chronic obstructive pulmonary disease but the prevalence of TB-induced airflow obstruction (AO) is still unknown.To measure frequency of AO in new TB cases at the beginning of treatment an
Autor:
Simon Tiberi, Lorenzo Guglielmetti, Pier Francesco Giorgetti, Emanuele Pontali, Jaime Esteban, Monica Rios Prego, Christoph Lange, Gina Gualano, Zorica Nanovic, Anne Margarita Dyrhol-Riise, Jalal Miah, Fabrizio Palmieri, Andrii Dudnyk, Berit Lange, Enrico Girardi, Ivan Solovic, Katerina Manika, Jan Heyckendorf, M. Nieves Altet Gomez, Assunta Navarra, Monica Sañé Schepisi, Anna Kaluzhenina
Publikováno v:
RUNA. Repositorio da Consellería de Sanidade e Sergas
Servizo Galego de Saúde (SERGAS)
Open Forum Infectious Diseases
Open Forum Infectious Diseases, Oxford University Press, 2019, 6 (1), pp.ofy337. ⟨10.1093/ofid/ofy337⟩
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Servizo Galego de Saúde (SERGAS)
Open Forum Infectious Diseases
Open Forum Infectious Diseases, Oxford University Press, 2019, 6 (1), pp.ofy337. ⟨10.1093/ofid/ofy337⟩
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Background. The growing burden of diabetes mellitus (DM) is posing a threat to global tuberculosis (TB) control. DM triples the risk of developing TB, modifies the presenting features of pulmonary TB, and worsens TB treatment outcomes. We aimed to an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1313b42f2823388f7cd323fa1807fe8a
https://www.ncbi.nlm.nih.gov/pubmed/30697572
https://www.ncbi.nlm.nih.gov/pubmed/30697572
Autor:
S. Samper, Alicia Lacoma, Vicenç Ausina, L. Haba, J. Ruiz-Manzano, José Maldonado, Cristina Prat, Jessica Diaz, Barbara Molina-Moya, José Domínguez, Andrii Dudnyk
Publikováno v:
Journal of Infection. 70:400-408
Summary Objectives To determine the sensitivity and specificity of AID TB Resistance line probe assay (AID Diagnostika, Germany) to detect Mycobacterium tuberculosis and its resistance to first- and second-line drugs in clinical samples using BACTEC
Publikováno v:
Respirology. 23:636-637
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 22:121-122